Analyzing Johnson & Johnson's Steady Growth, Dividend, and Analyst Outlook episode artwork

EPISODE · Mar 18, 2025 · 2 MIN

Analyzing Johnson & Johnson's Steady Growth, Dividend, and Analyst Outlook

from Johnson & Johnson News Daily · host Inception Point AI

As of the latest update, Johnson and Johnson's stock price is around one hundred sixty-two dollars and twelve cents per share. The trading volume has been notably lower than average, with recent days seeing a significant decline compared to the usual daily volume. For instance, on a recent trading day, the volume was eighty-two percent below the average daily volume of approximately seven million, three hundred thirty-two thousand shares. Recently, Johnson and Johnson reported strong fourth-quarter results for two thousand twenty-four, with a five-point-three percent increase in sales. The company's MedTech segment showed significant growth, driven by electrophysiology products and wound closure solutions. For the full year two thousand twenty-five, Johnson and Johnson expects operational sales to grow between two-point-five and three-point-five percent. In terms of analyst updates, several firms have adjusted their price targets for Johnson and Johnson. Bank of America raised its target from one hundred fifty-nine dollars to one hundred seventy-one dollars, while Royal Bank of Canada maintained an outperform rating with a target of one hundred eighty-one dollars. Citigroup reduced its target from one hundred eighty-five dollars to one hundred seventy-five dollars but maintained a buy rating. Overall, the consensus among analysts is a moderate buy with a target price of approximately one hundred seventy-one dollars and thirty-three cents. Johnson and Johnson also recently announced a quarterly dividend of one dollar and twenty-four cents per share, reflecting a yield of approximately three-point-zero-four percent. The company's financial health and consistent dividend payouts make it an attractive option for investors seeking stability. Despite the recent low trading volume, Johnson and Johnson remains a significant player in the healthcare sector, with a market capitalization of nearly three hundred ninety-four billion dollars. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.

Episode metadata supplied by the publisher feed · Published Mar 18, 2025

Embed this episode

NOW PLAYING

Analyzing Johnson & Johnson's Steady Growth, Dividend, and Analyst Outlook

0:00 2:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Johnson & Johnson News Daily?

This episode is 2 minutes long.

When was this Johnson & Johnson News Daily episode published?

This episode was published on March 18, 2025.

Can I download this Johnson & Johnson News Daily episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!